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Keratin 17 (Krt17; K17) is an intermediate filament protein known to be robustly 
upregulated in many types of epithelial-derived tumors. Recently, we have reported that K17 
is capable of localizing to the nucleus of tumor-prone skin keratinocytes, where it can 
associate with chromatin, positively regulate the expression of pro-inflammatory chemokines 
and cytokines, and promote tumorigenesis. Given that K17 is known to be robustly 
upregulated in many types of epithelial-derived tumors and is required for timely tumor 
onset in two distinct transgenic mouse models for spontaneous skin tumorigenesis, we 
hypothesize that nuclear-localized K17 may play a role in regulating DNA damage and 
genome instability, a key enabler of early tumorigenesis. To investigate this possibility, we 
subjected human skin tumor cells lines, both parental and CRISPR/Cas9-generated Krt17 
null, to three molecularly distinct paradigms of DNA damage (1 ug of DMBA for 12 hrs, 
100 uM H2O2 for 30 min, and 2 Gy ionizing radiation). In parental cells (expressing K17), all 
treatments triggered a robust DNA damage and repair response (DDR) as assessed by 
immunoblotting and immunostaining for DDR markers (including γH2AX pp53, pATM, 
pATR, pBRCA1, pCHK1, pCHK2), as well as by the comet assay to measure the extent of 
physical DNA damage. In striking contrast to parental skin tumor keratinocytes, we observed 
a significant attenuation of DDR for every readout in Krt17 nulls across all three distinct 
DNA damage treatments. Re-expression of wildtype K17 into Krt17 null cells completely 
restored the ability for DNA damaging agents to initiate the DDR. However, re-expression 
with wildtype K14, K16 and ΔNLS K17, which is a genetic variant lacking a functional 
nuclear localization signal, did not restore the ability of DNA damaging agents to induce the 
DDR. In addition, preliminary analysis suggests a chromatin organizational role for K17, 
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since K17 parental cells were more susceptible to micrococcal nuclease digestion, as 
opposed to the Krt17 nulls. Taken together, these findings display a novel and specific role 
for nuclear K17 to regulate the DNA damage response in skin tumor keratinocytes, 
suggesting that K17 may act as a key regulator of both inflammation and genome instability 
during early tumorigenesis.  
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Cancer: A Chronic Disease through the Ages 
Cancer is not a simple disease. It is a chronic condition driven by genomic instability, 
which leads to an accumulation of DNA mutations, resulting in uncontrolled growth and 
proliferation of abnormal cells (Fearon & Vogestein, 1990). Genome wide analyses have 
demonstrated that this disease involves a plethora of atypical complex signaling pathways to 
ultimately abolish homeostatic conditions of the cell (Quigley et al., 2009). These conditions 
become fatal for the individual when the metastasis cannot be controlled and it leads to 
physiological stress and organ failure. Due to the complex nature of cancer, the medical and 
scientific community have been relentlessly studying the mechanisms of tumorigenesis.   
Many efforts to combat the disease are through preventative measures, such as 
mammography screening for breast cancer and colonoscopy screening for colon cancer. These 
measures will allow earlier diagnosis of the cancer and can be immediately treated at its early 
phases. By detecting a cancer in its early stages, there is a much higher success rate for 
removing the tumor with no recurrences. Cancer staging is based on the size of the tumor or if 
it has spread to adjacent lymph nodes. Generally, if the cancer cells still reside in the layer of 
cells where they developed and haven’t spread, they are staged as in situ. However, if the 
cancer cells have penetrated beyond the original tissue, the cancer cell is deemed invasive. 
Clinically, the TNM staging system is used (Edge et al., 2010). It assesses cancer growth and 
spread by evaluating the extent of the primary tumor (T), absence or presence of regional 
lymph node involvement (N), and absence or presence of distance metastases (M). Once a T, 
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N, or M category is assigned, the stage is then assigned. It can be stage 0, which is in situ, stage 
I being early, and stage IV being the most advanced disease stage.  
These different stages of cancer metastasis are dependent on the aggressiveness of the 
tumor, which is reliant on the six hallmarks of cancer: 1) evading apoptosis; 2) self-sufficiency 
in growth signals; 3) insensitivity to anti-growth signals; 4) tissue invasion & metastasis; 5) 
limitless replicative potential; 6) sustained angiogenesis. (Hanahan & Weinberg, 2000). Each 
of these hallmarks are representative of characteristics that ignore cellular homeostatic 
conditions to induce aggressive progression of a tumor. Recent data suggests that there are 
additional attributes that are functionally important for cancer development (Hanahan & 
Weinberg, 2011). These new attributes are separated into two categories: Emerging Hallmarks 
and Enabling Characteristics. The first emerging hallmark of cancer is the capability for cancer 
cells to alter its metabolic pathway to ensure neoplastic proliferation, and the second is the 
ability to evade immune surveillance from lymphocytes. In addition, cancer cells contain high 
levels of genomic instability, which results in DNA mutations, giving these cells to drive tumor 
progression. This enabling characteristic is accompanied by cytokine expression by the innate 
immune system, which may trigger tumor-promoting inflammation.  
DNA damage and its role in carcinogenesis  
As such, genetic instability and inflammation are key enablers of tumor initiation. 
Genetic instability is attributed to DNA damage, caused by various agents that are capable of 
disrupting the structure of nucleic acids (O’Connor, 2015). Such examples of DNA damaging 
agents include chemical carcinogens, oxidative reagents, and external sources of ionizing 
radiation. DMBA is a polycyclic aromatic hydrocarbon, a potent carcinogen that is known to 
have mutagenic properties on DNA after exposure, forming various DMBA-DNA adducts 
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(Dipple et al., 1984; Slaga et al., 1974; Ward et al., 1986). More importantly, DMBA is a 
commonly utilized as initiating agents in the two-step carcinogenesis experimental protocol 
(Abel et al., 2009). Another agent that is known to initiate DNA damage is hydrogen peroxide, 
where it is commonly known to create free radicals known as reactive oxygen species (ROS) 
when metabolized by the cells. These ROS are known to cause significant damage to the DNA 
as well, by abstracting the electrons on nitrogenous bases, resulting strand breaks and 
alterations in the DNA (Burdon et al., 1996). Likewise, ionizing radiation (IR) can cause DNA 
damage as well, by directly inducing both single-strand breaks (SSB) and double-strand breaks 
(DSB) in the DNA double helix backbone. If misrepaired - for example, the inaccurate 
rejoining of broken DNA ends at DSBs - such breaks can induce mutations and lead to 
widespread structural rearrangement of the genome (Lord & Ashworth, 2012).  
Evoking DNA damage will trigger the DNA damage response (DDR), which is a 
collective term for the plethora of different intra- and inter-cellular signaling events and 
enzyme activities that result from the induction and detection of DNA damage. These include 
events that lead to cell-cycle arrest, regulation of DNA replication, and the repair or bypass of 
DNA damage. Should DNA repair not be possible or subpar repair leads to a continuous level 
of genomic instability, DDR can also impact on cell fate decisions, such as cell death or 
senescence (d’Adda di Fagagna et al, 2003; Kang et al., 2015).  
Recent analysis suggests that there are over 400 proteins essential to DDR (Pearl et al., 
2015), each playing a significant role in the signaling cascade of DDR. A canonical DDR 
pathway has been established, where, upon insult, the MRE11-RAD50-NBS1 complex will 
detect damage and phosphorylate two central transducers, ATM and ATR (Zou and Elledge, 
2003). When phosphorylated, these two proteins will act as kinases and phosphorylate H2AX, 
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BRCA1, CHK1, and CHK2 (Figure 1). These activated kinases will further phosphorylate 
targets such as p53 and CDC25 to influence the fate of the cell.  
The phosphorylation of histone variant H2AX on serine-139, also referred to as 
γH2AX, rapidly occurs upon DNA damage, in both single-strand and double-strand breaks 
(Sharma et al., 2012). The phosphorylation event of this histone variant creates foci within the 
cell nucleus, indicative of the number of DNA breaks, as well as the extent of the damage 
(Lobrich et al., 2010) The purpose of γH2AX is to modify chromatin structure and associate 
with other DDR proteins, which also includes the repair machinery, allowing it access to 
initiate DNA repair. γH2AX as a marker of DNA damage has been thoroughly reported and 
utilized in a variety of experimental assays such as immunostaining, immunoblotting, all which 
have reported the efficiency and reliability of this moiety as a marker for DNA damage (Mah et 
al., 2010; Sharma et al., 2012). Thus, the levels of γH2AX under these experimental conditions 
is an accurate indicator of DNA damage.  
On the topic of DDR, there has also been further evidence showing a crosstalk between 
chromatin state and the DDR (Sulli & Di Micco & d’Adda di Fagagna, 2012). Chromatin can 
affect the sensitivity of DNA to DNA-damaging agents. Evidence for this has come from 
studies showing that, on exposure to ionizing radiation, DNA that is depleted of histones, or of 
other chromatin-associated proteins, promoting a euchromatin state resulted in more lesions 
compared with compacted chromatin (Costes et al., 2007; Elia & Bradley, 1992). It is clear that 
in addition to physically shielding DNA from damage, the chromatin structure also affects local 
DDR signaling around DNA damage. For example, heterochromatin seems to be resistant to 
γH2AX induction, whereas a shift to a euchromatin state promotes γH2AX induction (Di 
Micco et al., 2011; Kim et al., 2007). Furthermore, decreasing the degree of heterochromatin 
5 
 
structure by inhibiting histone deacetylases (HDACs), which decreases chromatin compaction 
by removing acetyl groups from histones, or by reducing the levels of histone H1, enhances 
DDR signaling and the extent of γH2AX activation (Cowell et al., 2007; Murga et al., 2007).  
Other recent studies such as the one carried out by Wu et al. (2010) reported that the 
loss of two E3 ubiquitin ligases, RNF8 and Chfr, are vital to the DDR by controlling H4 Lys 16 
acetylation though MRG-dependent acetyltransferase complexes, promoting chromatin 
relaxation, hence allowing recruitment and activation of ATM and other DNA damage 
response moieties. To further substantiate this complex interplay between chromatin 
architecture and the DNA damage response, a recent group from Cambridge has reported that 
the DNA damage response is modified through two histone deacetylases: HDAC1 and 
HDAC2, specifically altering the state of H3 Lys 56 acetylation and H4 Lys 16 acetylation 
(Miller et al., 2010). In addition, the data showed that cells depleted of histone deacetylases 
were hypersensitive to DNA-damaging agents and showed sustained DNA damage signaling, 
as reflected upon a lack of non-homologous end-joining (NHEJ) repair mechanism. This 
suggests that HDACS, whose canonical role in physiology is chromatin organization, are able 
to modulate the DNA damage response by promoting Double strand breaks (DSB) repair.  
Overall, chromatin conformation can be hypothesized as an important component of the 
activation of DDR signaling, which then plays a role in determining the fate of the cell. 
Interestingly, a common characteristic of many tumor types is the euchromatic nature of their 
chromosomes, suggesting that cancer cells, through the expansion of the euchromatin structure, 
may allow heightened sensitivity to damaging agents, as well as oncogene activation (Sulli, Di 
Micco & di Fagagna, 2012).  
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Figure 1. The DNA damage response. The DNA damage response (DDR) pathway is composed of two main 
DNA sensors: the MRN complex (MRE-11-RAD50-NBS1) and the RAD9 complex (RAD9-RAD1-HUS1), where 
they detect double-stranded breaks and single-stranded breaks, respectively. These sensors of damage then recruit 
the apical kinases ATM (through the MRN complex) and ATR (through RAD9 complex) for activation, which in 
turn, will phosphorylate histone variant H2AX on serine 139. ATM is seen activated more by DSB and ATR is 
more responsible for other types of genotoxic stress such as single-stranded breaks. γH2AX is required to recruit 
MDC1 to amplify DDR signaling via a positive feed-back loop between ATM and the MRN complex. Other DDR 
moieties are recruited and phosphorylated as well, such as CHK1 and CHK2, which in turn will activate 
downstream effectors such as p53 and CDC25 that modulates cell cycle arrest and apoptosis. Figure adapted from 







 Keratins: A novel family of intermediate filaments  
 Most eukaryotic cells contain in their cytoplasm an elaborate cytoskeletal system 
consisting of intermediate filaments (IFs), which are chemically very stable and long filaments 
of ~10 nm in diameter (Fuchs & Cleaveland, 1998; Kim & Coulombe, 2007). Among the 
various families and subfamilies of IF proteins, keratin genes represent the largest group with 
54 distinct functional genes (28 type I and 28 type II) which are highly expressed in epithelial 
type cells and regulated in a cell-type and context-dependent manner (Schweizer et al., 2006; 
Sun et al, 1983). The classification of keratins as type I and type II IFs is based on basic 
features such as gene substructure and sequence homology (Figure 2A; Coulombe, Bernot & 
Lee, 2013; Fuchs and Marchuk, 1983; Moll and Divo, 2008).  
Keratins readily self-assemble into 10 nm filaments in vitro and in vivo and localize to 
the cytoplasm under normal physiological conditions (Figure 2C; Gu & Coulombe, 2005; 
Coulombe and Omary, 2002; Yamada et al., 2002). Keratins have a tripartite structure with an 
N-terminal head, a central rod, and C-terminal tail domains (Figure 2B; Coulombe, Bernot & 
Lee, 2013; Bragulla & Hoberger, 2009). Keratin IF proteins have molecular weights ranging 
from 40 to 70 kDa (Schweizer et al., 2006; Sun et al., 1983). Keratin filaments are obligatory 
heteromeric assemblies with type I and II moieties occurring in a 1:1 molear ratio. The central 
rod domain of keratins features long-range heptad repeat of hydrophobic amino acids that 
allow the formation of coiled-coil interaction to allow pairing between type I and type II 
keratins (Coulombe & Fuchs, 1990; Hatzfeld &Weber, 1990). It is important to understand that 
the expression of type I and type II keratin genes is coordinately regulated in a differentiation 
and context-specific fashion specific in epithelial cells and tissues. For example, the type II 
Krt5 and type I Krt14 are expressed together in the basal progenitor layer of epidermis and 
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related complex epithelia, whereas type II Krt8 and type I Krt18 are expressed in simple 













Figure 2. The keratin structure and its organization. (a) The keratin proteins are organized into type I and type 
II keratins based on primary protein sequence homology. (b) Schematic of keratin secondary structure. All 
keratins share a tripartite structure consisting of a head, tail, and central α-helical rod domain that plays in the role 
of self-assembly. (c) Electron microscopy image of in vitro reconstructed filament from purified keratin 5 and 
keratin 14 proteins. Scale bar = 500 μm. (d) Triple-labeling for keratin (in red) and desmoplakin, a desmosome 
component (in green) and DNA (in blue) by indirect immunofluorescence of epithelial cells in culture. Scale bar = 









Functional roles of keratins 
It has now long been established that keratin intermediate filaments are vital for the 
mechanical stability and integrity of epithelial cells and tissues (Fuchs and Coulombe, Cell 
1992; Gu & Coulombe, 2007). Although type I and type II keratins are absolutely essential in 
maintaining cellular architecture, as was originally established in the setting of a rare disorder, 
epidermolysis bullosa simplex (EBS) (Fuchs and Coulombe, Cell 1992; Coulombe, J Invest 
Dermatol 2017). Disease causing mutations such as frameshift mutations and point mutations 
affecting the tail domain encoding exon of epidermal keratins are associated with different 
forms of epidermolysis bullosa simplex (EBS), epidermolytic hyperkeratosis (EHK) and other 
related diseases (Gu et al., 2003). EBS and EHK are classical skin fragility disorders that result 
from genetic defects in keratin proteins and the keratin network of specific subpopulations of 
keratinocytes in the epidermis. It was discovered most EBS are due to dominantly acting 
mutations in either K5 or K14, whereas K1 and K10 are most mutated in EHK (Fuchs and 
Coulombe, Cell 1992; Omary et al., NEJM 2004).  
Additional, non-canonical functions have been identified for keratin proteins, such as 
their ability to interact with organelles through a number of mechanisms. Recent data has 
showed keratins to regulate the positioning and morphology of organelles such as the 
mitochondria, subsequently affecting their functionality (Toivola et al., 2005). Keratin proteins 
also have regulatory functions and are involved in intracellular signaling pathways, e.g. 
protection from stress, wound healing, inflammation, cell growth and apoptosis (Moll & Divo, 
2008; Paladini & Coulombe; Chung et al, 2015). A specific keratin that has been implicated in 
a variety of cellular signaling processes is the type I protein, keratin 17 (K17), as detailed in the 
next section.  
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Physiological roles of keratin 17  
Keratin 17 is a type I keratin of 46 kDa in mass (432 amino acids in the human; 
Troyanovsky et al., 1992). At baseline, the KRT17 gene is constitutively expressed in 
ectoderm-derived epithelial appendages such as the hair follicle, nail beds, tooth, thymus, and 
various glandular epithelias. Furthermore, KRT17 is induced upon woulding for tissue repair, 
which along with carcinomas is a setting of enhanced cell proliferation and altered 
differentiation (Mansbridge & Knapp, 1987; McGowan & Coulombe, 1998).  The bulk of 
information available on K17 functions in normal physiology is derived from the research 
performed in a Krt17 null mouse model by McGowan & Coulombe (2002). Structurally, K17 
protein has been reported to play a role in the postnatal hair follicle, by providing mechanical 
support to the hair shaft and maintaining the viability of hair-producing epithelial cells 
(McGowan & Coulombe, 2002). In addition, K17 influences apoptotic signaling, with studies 
that reveal a relationship between K17 and TNF-α to regulate hair follicle cycling. TNF-α is a 
powerful and pleiotropic signal with a vast array of physiological functions such as eliciting the 
immunological response and promoting apoptosis. K17 has been reported to modulate TNF-α 
signaling in hair follicles likely through its interaction with an adaptor protein called TRADD, 
which promotes their persistence in the anagen, growth-promoting state (Tong & Coulombe, 
2006). 
Additional studies such as the one carried out by Kim et al. (2006) described a new 
function of K17, where it was reported to impact the signaling pathway and regulation of cell 
growth by binding directing with adaptor protein 14-3-3σ to stimulate the mTOR pathway, 
most notably regulating protein synthesis and epithelial cell growth post-wounding (Kim et al,, 
2006). Imbalance of mTOR function has been associated with many classes of cancers such as 
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colon, gastric and hepatocellular carcinomas, and has a significant effect of tumor progression 
(Kim & Eng 2011; Populo et al., 2011; Villaneuva et al., 2008) So far, the functional relavance 
of K17 is not understood fully yet, but emerging evidence on several fronts converge in 
establishing that K17 is playing a significant role in various signalling events that impacts cell 
growth and proliferation.  
Keratin 17 and its role in tumorigenesis   
There has been a vast body of work that indicates K17 plays a functional role in 
tumorigenesis. Recent evidence showed that high expression of K17 is correlated with the 
expression of epidermal growth factor receptor (EGFR), which is known to be associated with 
poor prognosis through Kaplan Meier survival analysis in the head and neck, ovarian, cervical 
and esophageal cancers (Bauknecht et al., 1989; Ozawa et al., 1980; Wang et al., 2013). 
Furthermore, these investigators also noted that K17 expression correlates with the level of 
tumor aggression, as well as its progression. Preliminary research on this intermediate filament 
noted K17 to be prominent in basal cell carcinomas (BCC), observed by Markey et al. (1992) 
through a study of  utilizing immunohistochemistry staining to visualize K17 expression in situ 
(also, see Moll et al., 1982). In addition, a clinical study performed by Goyal et al. (2016) also 
noted high expression of K17 in cutaneous lymphadenoma (CL), which is a rare neoplasm that 
is clinically and histologically similar to BCC. Overall, K17 expression appears to be 
prominent in many disease settings, such as cervical carcinomas, where the level of K17 
expression is both a reliable diagnostic and prognosis biomarker.   
Investigation of K17 in other pathologies has provided more detailed insight into the 
molecular mechanisms by which K17 contributes to cancer. Early studies by Liao et al. (2016) 
utilized a murine model of radiation dermatitis, and sought to understand the role K17 plays in 
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skin epithelia under the exposure of ionizing radation. Results indicated that K17 expression is 
initially down-regulated after initial ionizing radiation treatment and is up-regulated upon after 
chronic exposure to ionizing radiation. The down-regulation correlated with the activation of 
p53 signaling, hence the investigators predicted a relationship between K17 and p53 (Liao et 
al., 2016). Deletion of p53 abolishes the initial down-regulation of K17 upon damage, but not 
its up-regulation, which may suggest p53 suppresses K17 transcription, as opposed to 
suppression through post-translational modification. Taking advantage of chromatin 
immunoprecipitation (Co-IP) and electromobility shift assay, results identified two p53 binding 
sites in the promoter region of KRT17, leading to the concludion that in response to ionizing 
radiation p53 works to suppress KRT17 expresson.  
Recent evidence by DePianto et al. (2010) showed that BCC development is due to K17 
expression. A transgenic model in mice for BCC was developed whereby the transcription 
factor Gli2 is constitutively expressed using the KRT5 gene promoter, leading to sustained 
activiation of the Sonic hedgehog (Shh) signaling pathway and development of basaloid skin 
tumors (Grachtchouk et al., 2000).  Interestingly enough, the genetic ablation of Krt17 in the 
setting of this Gli2tg mouse model significantly attenuates the extent of basal cell-like lesions 
(Figure 3a; DePianto et al., 2010). Specifically, loss of Krt17 markedly delays the onset of 
tumor in ear skin of Gli2tg mice (Figure 3b; DePiantoet al., 2010). Loss of Krt17 in this setting 
also results in reduced tumor keratinocyte proliferation and inflammatory cytokine expression. 
qRT-PCR analysis indicated a shift of cytokine expression from pro-inflammatory to anti-
inflammatory, further complementing these findings. In addition, this phenomenon was K17 
specific, since genetic ablation of Krt14 did not display a significant impact in the the onset of 






















Figure 3. Genetic ablation of K17 delays tumor onset of basal cell carcinoma in ear epithelia. (a) Left panel 
indicates that P80 Gli2Tg mice spontaneously develop ear lesions, but the onset of BCC-like lesions is delayed in 
the K17 null mice. Right panel is a hematoxylin-eosin stained ear tissue showing a dramatic reduction of thickness 
of the ear upon genetic ablation of K17. (b) Percentage of mice with ear lesions divided among sexes and 
genotype within a P40-P120 timeframe displayed a delayed tumor onset upon genetic ablation of K17 but no 
difference in the delay among the sexes. (c) Quantification of percentage of mice with tumor seen in K17 null at 
P80 and representative of this as a K17 specific event when compared with the K14 null mice. Figure adapted 
from DePianto et al., 2010.  
 
Building upon this work, a separate transgenic mouse model for squamous cell 
carcinoma (SCC) was developed by Arbeit et al. (1994) and also exploited by the Coulombe 
laboratory to further investigate K17’s role in tumorigenesis. This model entails the expression 
of the open early genes of human papillomavirus type 16 (HPV16) using the KRT14 gene 
promoter and elicits the formation of SCC-like lesions in ear skin (Arbeit et al., 1994; Munoz et 
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al., 2006). Of note, this model is is different genetic strain background (FVB) relative to the 
Gli2tg model (C57Bl/6). Hobbs et al. (2015) recently reported that genetic ablation of Krt17 in 
the HPV16Tg/+ setting (HPV16Tg/+ Krt17-/-) dramatically reduced epidermal thickness in the ear 
tissue, complemented with a reduction of pro-inflamatory cytokine induction and mitotic 
activity (Figure 4; Hobbs et al., 2015). Follow-up efforts to investigate the molecular 
mechanisms whereby K17 impacts tumorigenesis and inflammation showed a physical and 
functional interaction between K17 and AIRE (autoimmune regulator), a transcriptional 
regulator, and between K17 and hnRNPK, a ribonucleoprotein, which both influence the level 
of cytokine gene expression (Hobbs et al, 2015; Chung et al., 2015).  
 
Figure 4. Loss of K17 attenuates squamous cell carcinoma development. (a) Hematoxylin-eosin stain of 
HPV16Tg/+ and HPV16Tg/+; Krt17-/- mouse ear sections display a significant increase in epidermal thickness. 
Quantification of epidermal thickness at both pre-lesional and lesional time points between wild-type, HPV16Tg/+, 
and HPV16Tg/+; Krt17-/- are seen on the right. All scale bars = 20 μm. (b) TPA treated tumor keratinocytes (A431) 
in culture showed an induction of pro-inflammatory cytokine expression relative to DMSO treated keratinocytes. 
HPV16Tg/+ ear skin tissue showed higher levels of pro-inflammatory cutokine expression as well relative to WT 






Keratin 17 localizes into the cell nucleus 
While investigating the mechanisms underlying the ability of K17 to regulate the 
expression of pro-inflammatory cytokines, Hobbs et al. (2015) also observed that K17 can 
translocate into the nucleus of human and mouse tumor keratinocytes . A similar observation 
was made by Escobar-Hoyos et al. (2015), whereby K17, functioning as an oncoprotein in the 
cervix, breast, and pancreatic cancer cells, is able to regulate the subcellular localization and 
degradation of p27KIP1, a protein that inhibits the activity of cyclin-dependent kinases, thus 
halting the cell cycle. K17 is able to translocate into the nuclus via a nuclear localization signal 
(NLS) to bind p27KIP1 for degradation. Depletion in endogenous p27KIP1 prompts the 
cellular machinary to continue dividing, resulting in tumorigenesis. In both of these studies, 
uncovering the presence of nuclear K17 in cultured tumor kerationcyes involved a potent 
inhibitor of CRM1/Exportin 1 mediated nuclear transport, Leptomycin B (LMB). This 
chemical compound is able to trap nuclear K17 inside the nucleus and facilitate the detection 
through fluorescent microscopy. Others have also adapted this strategy in visualizing 
cytoskeletal associated proteins, such as lipoma preferred partner, zyxin, ZO-2, and KEAP1 
(Petit et al., 2000; Nix et al., 2001; Islas et al., 2002; Velichkova & Hasson, 2005). 
Importantly, the NLS is a di-lysine motif located at lysines 399 and 400 in the tail 
domain moiety of human K17, which is highly conserved between humans and primates, 
rodents, amphibians and fish (Hobbs & Jacob, 2015). Cultured cell lines transiently transfected 
with K17 engineered by site-directed mutagenesis to contain an alanine instead of a lysine at 
residue 400 (ΔNLS K17) exhibited attenuated localization into the nucleus and a reduced 




 The limited knowledge accumulated to date regarding K17’s presence in the nucleus  
suggests that it may play multiple roles within the nucleus, as it has been seen to do so 
previously in the cytoplasm to regulate the homeostatic functions of the cell (Kim et al., 2006); 
McGowan et al., 2002; Tong & Coulombe, 2006). As reported by Hobbs et al. (2015), nuclear 
K17 associates with the promoter region of cytokine genes, as well as AIRE and the p65 
subunit of NF-kappaB. Taken together, the data suggest potential nuclear roles carried out by 
K17, such as binding to chromatin and transcription factors to regulate gene expression.  






Previous finding: Loss of K17 does not attenuate the DDR in the HPV mouse model 
As previously shown, the HPV16Tg/+ model is a well established paradigm for the 
development of epithelial lesions and subsequent squamous cell carcinomas that coincides with 
the pathophysiology observed in human SCC (Arbeit et al., 1994; Hobbs et al., 2015). This 
model was further utilized to investigate whether K17 expression correlated with and is 
required for an increased DNA damage and response. Previous research indicated that lesion 
development occurs between P60 and P120 in the HPV16Tg/+ ear tissue, with complete 
penetrance by P120 (Hobbs et al., 2015). From this piece of data, P50 was chosen as a pre-
lesional time point to assess levels of DNA damage and its associated response. Although both 
K17 and DDR associated proteins were both found to be robustly upregulated in the ear, tail, 
and back skin tissue of HPV16Tg/+ mice relative to that of WT control mice, the DDR was not 
observed to be K17-dependent at this time point in vivo. (unpublished data from Stefan 
Prendergast, 2016). From this, we speculated that K17-dependence could occur at distinct time 
points (earlier?) or in a distinct paradigm for initiating and promoting DNA damage . Thus, we 
decided to utilize to apply acute DNA damage protocols with an initial focus on in vitro cell 
culture experiments, using three different modalities to trigger a DNA damage response: 
Ionizing radiation (IR) for inducing double-strand breaks, 7,12-Dimethylbenz(a)anthracene 
(DMBA) for creating DNA-adducts, and hydrogen peroxide (H2O2), which is known to create 
both single-strand and double-strand breaks. 
Stimulation of K17 expression upon treatment with both DMBA and H2O2 
As a means of determining whether K17 is induced upon acute DNA damage, mouse 
keratinocytes in primary culture derived from male mice (P2, Krt17+/+) were isolated, treated 
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with either 1 ug of DMBA for 12 hours, 100 μM of H2O2 for 30 minutes, or the mock treatment 
(acetone). Indirect immunofluorescence microscopy images stained for K17 suggests that K17 
expression is induced upon treatment with DMBA and H2O2 compared to acetone control 
(Figure 5). Fluorescence signal quantitation shows that K17 protein levels are increased in 
treated keratinocytes compared to the control (p<0.005; Mock vs DMBA, p=0.002; Mock vs 
H2O2, p=0.003). This finding, along with the findings of unpublished data from the Coulombe 
lab, suggests that K17 may play a role in the initiating events of acute DNA damage. Further 
substantiating this finding, a similar experiment was carried out in vivo as well. Ear tissue 
sections from two-month-old female mice (Krt17+/-or Krt17 -/-) that had been treated with 
either 20 μg of DMBA or acetone (control) on the dorsal surface were immunostained for K17. 
The results (two biological replicates) revealed a significant induction of K17 when DMBA is 





Figure 5. K17 induction in mouse keratinocytes upon DNA damage agent insult.  Mouse keratinocytes in 
primary culture (from 2 day old neonates) were seeded on glass cover slips, treated with 1 μg of DMBA (12 hr) or 
100 μM H2O2 (30 min), fixed with 4% paraformaldehyde, permeabilized with 0.2% triton, and immunostained for 
K17 (indirect immunofluorescence). All scale bars = 20 μm. Signal intensity per cell is quantified in the graph to 













Figure 6. K17 induction in vivo upon DNA damage insult. 2 months old Krt17+/-or Krt17 +/+ female mice were 
treated topically on the dorsal ear surface (20 μg of DMBA dissolved in acetone on right ear, acetone only (mock) 
on left ear) two times, 24 hrs apart. Ear tissue was harvested 1 hr after the second treatment and embedded in OCT 
and frozen. 8 μm tissue cryosections were immunostained for K17 (indirect immunofluorescence). K17 is induced 
the interfollicular epidermis of the dorsal ear but not the ventral side upon treatment of DMBA. Images are 
representative of multiple tissue sections from two distinct biological replicates. All scale bars = 20 μm. Figure 
from R. Hobbs, 2017.  
 
Nuclear K17 co-localizes with γH2AX 
As described previously, indirect immunofluorescence microscopy data showed a 
correlation between the induction of K17 and treatment with DMBA. With the knowledge of 
the presence of nuclear K17, we sought out whether nuclear K17 may associate with γH2AX, a 
well-known DDR effector that resides within the nucleus and is known to be induced upon 
DNA damage, such as DMBA treatment. To do this, normal human epidermal keratinocytes 
(NHEKS) were first co-stained by indirect immunofluorescence with antibodies γH2AX and 
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PML, which has been reported to closely associate with K17 in tumor epithelial keratinocytes 
(unpublished observations, Coulombe laboratory) (Figure 7a). Building upon this finding, 
HeLa cells in culture were treated with 40 nM of LMB for 3 ½ hours, 100 ng/μL of TNF-α for 
3 hours, and 200 nM of TPA for 3 hours to induce the formation of intranuclear K17 punctae. 
Utilizing indirect immunofluorescence microscopy, images stained for both nuclear K17 and 
γH2AX showed co-localization between the two proteins (Figure 7b), suggesting that nuclear 








Figure 7. Nuclear K17 juxtaposed with γH2AX and PML bodies. (a) Normal Human Epidermal Keratinocytes 
(NHEK) were treated with 1 μg of DMBA (12 hrs) and immunostained for γH2AX and PML. The images 
represent distinct γH2AX foci its co-localization to respective nuclear proteins (arrows). (b) LMB-treated HeLa 
cells immunostained for K17 and γH2AX. The merge image to the right highlight K17-positive nuclear punctae 
(arrows) and co-localization with γH2AX is observed. All scale bars = 10 μm.  
 
Genetic ablation of K17 significantly attenuates the DDR response  
To further investigate whether K17 plays a pivotal role in the DDR response, the human 
epidermoid carcinoma cell line A431 (Adhikary et al., 2013) was utilized to address this 
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overarching question. CRISPR/Cas9 genome editing technology was used to genetically ablate 
Krt17, resulting in A431 KRT17 -/- cells (Hobbs et al., 2015). Parental cells and KRT17 null 
cells were treated in parallel with either DMBA (for 12 hours; Ganesan et al., 2013) or H2O2 
(for 30 min; Driessens et al., 2009) and analyzed using indirect immunofluorescence. As 
illustrated in Figure 8, the latter revealed an induction of γH2AX levels in parental cells, but a 
significant attenuation of γH2AX foci in null cells (p<0.005). This, along with previous data 
showing an inducible nature of K17 upon damage, suggests K17 is indeed required for the 
induction of the DDR (Figure 8). Again, to further corroborate this finding, a similar 
experiment was conducted in vivo, where ear tissue sections from two-month-old female mice 
(KRT17+/-or Krt17 -/-) were immunostained for γH2AX after treatment with DMBA or acetone 
control. Correlating with the in vitro results, γH2AX is seen to be more upregulated when K17 











Figure 8. K17 dependence on γH2AX induction. A431 skin tumor keratinocytes (parental= K17 expressing; 
KER17 null = CIRSPIR/Cas9 mediated genetic ablation of K17) were seeded on glass cover slips, treated with 1 
μg of DMBA (12 hrs) or 100 μM H2O2 (30 min), fixed with 4 % paraformaldehyde, 0.2% triton permeabilization, 
and indirect immunostained for γH2AX. All scale bars = 20 μm. Signal intensity per cell is quantified in the graph 











Figure 9. K17 dependence on γH2AX induction in vivo. 2 months old Krt17+/-or Krt17 -/- female mice were 
treated topically on the dorsal ear surface (20 μg of DMBA dissolved in acetone on right ear, acetone only (mock) 
on left ear) two times, 24 hrs apart. Ear tissues were harvested 1 hr after the second treatment and embedded in 
OCT. 8 μm tissue sections were immune stained for γH2AX. γH2AX is induced in the interfollicular epidermis of 
the dorsal ear but not the ventral side upon treatment of DMBA. Induction of γH2AX.is attenuated in the absence 
of Krt17. Images are representative of multiple tissue sections from two distinct biological replicates. All scale 
bars = 20 μm. 
 
Next, we sought to expand our assessment of the K17-dependence of the entire DDR 
pathway by examining the status of a broad range of DDR markers. Again, parental and null 
keratinocytes were treated with either DMBA or H2O2 for the indicated times and harvested for 
analysis via western immunoblotting. At the protein level, the occurrence of DNA damage is 
evident under these treatment conditions, as demonstrated by immunoblotting for γH2AX 
(Figure 10). Krt17-/-, however, showed an attenuation of γH2AX induction, parallel with the 
microscopy data observed earlier. The induction of other DDR markers, such as p-BRCA1, 
pATM, pATR, pCHK1, pCHK2, and p-p53 all displayed an increase in band intensity when 
treated with DNA damaging agents when K17 is present. Again, these same DDR markers 
displayed a visually distinct lower band intensity in the Krt17 null setting (Figure 10), 
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suggesting attenuation of the DDR. Taken together, K17 appears to not only impact γH2AX 











Figure 10. K17 impacts the canonical DNA damage response pathway upon insult. Immunoblotting analysis 
of total protein extracts prepared from A431 skin keratinocytes subjected to DNA damage agents showed that the 
DDR is activated in parental cells by DMBA or H2O2, as indicated by increased levels of phospho-ATM, 
phospho-ATR, phospho-Chk1, phospho-Chk2, phosphor-p53 and γH2AX. By comparison, cells lacking K17 
showed attenuation of the DDR.  
 
Nuclear-localized K17 is required for the DNA Damage Response  
To further dissect the impact K17 plays in the DNA damage response, a re-expression 
strategy was carried out to investigate whether transfection of a CMV-promoter-driven, 
wildtype K17-encoding GFP plasmid (Hobbs et al., 2015) is sufficient to restore the DNA 
damage response in Krt17-/- A431 cells. Using indirect immunofluorescence microscopy, levels 
of γH2AX in Krt17 null cells that successfully re-expressed wildtype K17 were compared to 
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neighboring untransfected cells. Quantitatively, there is a significant difference between the 
two, whereby successfully transfected cells displayed much higher induction of γH2AX when 
compared to “control” untransfected cells (in the same dish), indicating re-expression of Krt17 
is sufficient to rescue the DNA damage response (Figure 10). Taking a step further, cultures of 
Krt17 null A431 keratinocytes were transfected with the ΔNLS variant of GFP-Krt17, or 
wildtype GFP-Krt14, a type I keratin related in K17 in primary structure. Both ΔNLS GFP-
Krt17 and WT GFP-Krt14 were unable to rescue the induction of γH2AX, suggesting that that 
the nuclear-localized from of K17, specifically, is needed to foster a normal DNA damage 
response (wildtype K17 vs K17-ΔNLS, p=0.024; wildtype K17 vs wildtype K14, p=0.034; 
WT-K17 vs null, p=0.004. Taken together, this, along with the data presented above regarding 
K17’s interaction with γH2AX in the nucleus, hints at a “sensing” role K17 may play in 







Figure 11. Re-expression with K17, but not K14 or K17 lacking a nuclear localization sequence, restores the 
DDR in A431 tumor keratinocytes. Krt17 null A431 skin tumor keratinocytes were seeded on glass cover slips 
and subsequently transiently transfected with either GFP-K17, GFP-K14, or GFP-K17ΔNLS, treated with 1 μg of 
DMBA (12 hr), fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, and immunostained for 
γH2AX. Expression of GFP-K17, but not GFP-K14 or GFP-K17ΔNLS, restored the ability of Krt17 null cells to 
induce γH2AX expression following DMBA treatment. Signal intensity of γH2AX per cell expressing each 
construct is quantified in the graph to the right using ImageJ and Excel. All scale bars = 20 μm. n= number of cells 






K17 sensitizes DNA to more strand breaks 
 The idea of K17 playing a sensing role in the DDR by altering chromatin architecture is 
plausible, since it has already been seen to bind transcription factors such as AIRE (which has 
been reported to occur at double-strand DNA breaks; Anderson & Su, 2016) and the p65 
subunit of NF-kappaB (Hobbs et al., 2015). As already mentioned above, recent literature 
reports on the occurrence of crosstalk between DNA damage and the organization of the 
chromatin (Sulli & Di Micco & d’Adda di Fagagna, 2012), as well as a significant role for K17 
in modulating the onset of tumorigenesis and pro-inflammatory expression in vivo (DePianto et 
al., 2010; Hobbs et al., 2015) and ex vivo (Chung et al., 2015). Together with the data reported 
so far in this thesis, this body of evidence indeed suggests that the presence of nuclear K17 may 
play a role in sensing DNA damage by possibly altering the chromatin structure in a manner 
that results in higher susceptibility to external insults. To address this question, we next turned 
to the comet assay, which has been extensively utilized as an indicator for both single-strand 
and double-strand DNA breaks (Fairbaim, Olive & O’Neill, 1995). A431 skin keratinocytes 
(Krt17+/+or Krt17 -/-) were treated with DMBA (12 hrs) and H2O2 (30 min), as described above, 
and cells were next suspended and plated on an LMN agarose slide and subjected to 
electrophoresis (see Materials and Methods). As observed in all four biological replicates 
(n=4), the parental cells treated with either DMBA or H2O2 showed significant longer tail 
moments compared to the null (p=0.002), indicative of a higher extent of DNA fragmentation 
(Figure 11). This finding is in accord with the hypothesis described previously, where K17’s 
sensing mechanism in the DDR is sensitizing the chromatin to fragmentation. To further 
substantiate these findings, ionizing radiation (IR) experiments were carried out to investigate 
if K17 does really impact the level of DNA breakage, since IR is a very reliable source of 
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causing double strand breaks (DSB), thereby fragmenting DNA. Doses of 2 Gy and 20 Gy 
were chosen for indirect immunofluorescence microscopy and comet assays, respectively. As 
shown below, (n=3 biological replicates) there is a K17 dependence on DNA breakage 
indicated by a higher γH2AX signal intensity, which also shows that K17 dependence on DNA 
breakage is correlated with a more robust DNA damage response. (Figure 12). The alkaline 
comet assays treated with irradiation also shows K17 dependence on DNA fragmentation, 










Figure 12.  Depletion of K17 attenuates DNA breakage. A431 skin tumor keratinocytes were subjected to DNA 
damaging agents and processed immediately post DNA damage for an alkaline comet assay to assess DNA 
fragmentation. Longer tail moments are observed in parental cells when exposed to various insults, which are 














Figure 13. K17 dependence on γH2AX induction under ionizing radiation A431 skin tumor keratinocytes 
(parental= K17 expressing; Krt17 null = CIRSPIR/Cas9 mediated genetic ablation of K17) were seeded on glass 
cover slips, treated with 2 Gy ionizing radiation, fixed with 4 % paraformaldehyde, 0.2% triton permeabilization, 
and indirect immunostained for γH2AX. All scale bars = 20 μm. Signal intensity per cell is quantified in the graph 














Figure 14.  Depletion of K17 attenuates DNA breakage under ionizing radiation. A431 skin tumor 
keratinocytes were subjected to 20 Gy ionizing radiation and processed for an alkaline comet assay to assess DNA 
fragmentation. Longer tail moments are observed in parental cells when exposed to various insults, which are 
substantially reduced in the absence of K17. Treatment conditions are as the same as above. All scale bars = 20 
μm. Tail moment lengths per cell is quantified in the graph at the right using ImageJ and Excel. n= number of cells 
counted. *p<0.005 (Student’s t-test). 
 
The use of a micrococcal nuclease digestion assay (MNase) is well documented in the 
literature as a means to assess general chromatin architecture (Yamasaki et al., 2007; Wu et al., 
2011; Ziv et al., 2006). Micrococcal nuclease is an enzyme that cleaves transcriptionally active 
sites, thus, a euchromatin state will be more prone towards degradation by this enzyme. The 
cleaved fragments are subsequently subjected to agarose gel electrophoresis to visualize the 
banding patterns. This assay has been utilized in countless investigations to address questions 
such as histone modifications and its ability to impact chromatin structure (Wu et al., 2015).  
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 To test whether K17 actually impacts chromatin organization, parental and Krt17 null 
A431 skin keratinocytes were permeabilized with lysolecithin, allowing micrococcal nuclease 
to translocate into the nucleus and cleave at transcriptionally active sites on the DNA. 
Ethylenediaminetetraacetic acid (EDTA) and proteinase K (Monico et al., 2017) was added in a 
stop solution to halt genome digestion. The micrococcal nuclease enzyme was added for 
increasing time periods to assess the state of chromatic packing (see Materials and Methods). 
Here, we report that K17 impacts the extent of MNase-dependent DNA fragmentation, whereas 
cellular DNA was more susceptible to MNase digestion in its presence (Figure 13b). To 
complement these findings, a distinct DNA fragmentation assay was performed following 
exposure to ionizing radiation (IR) as a direct inducer of double strand DNA breaks. The 
rationale here is to probe for a potential interdependency between K17’s role in sensing DNA 
damage and its potential role in influencing chromosome architecture. To first assess the 
paradigm of IR induced fragmentation, parental cells and nulls were subjected to 2 Gy or 20 
Gy of IR, as previously described (Puck & Markus, 1956), and lysed to extract DNA for the 
purpose of gel electrophoresis. Qualitatively, the results obtained paralleled the data observed 
in the MNase experiments, with the presence of K17 significantly increasing the extent of 
DNA fragmentation (Figure 13a). Taken together, these findings suggest that the presence of 
K17 alter chromatin architecture so as to promote a euchromatin, looser state, thereby 























Figure 15. K17 leads to higher levels of DNA fragmentation. A431 skin tumor keratinocytes were subjected to 
a range of ionizing radiation (IR) or various concentration of micrococcal nuclease. DNA was isolated and ran on 
an agarose gel. Lower molecular weight bands were more prominent in the parental cells, where the absence of 
K17 appeared to be more resistant to DNA fragmentation.  
 
Discussion 
The research project described in this thesis uncovers a novel role of K17 in specifying 
the sensitivity and/or the repair response for three different DNA damage paradigms, and as 
such has significant implications for the impact of K17 at the time of tumor initiation in vivo.  
Stemming from the extensively reported observation that K17 is induced in a variety of 
stress/inflammatory settings, and coupled with the knowledge that K17 directly impacts the 
course of tumorigenesis through a number of mechanisms, we sought to investigate whether 
K17 plays a role in the initiation stage of tumorigenesis, through subjecting cultured cell lines 




involving mouse skin. This acute model is a logical choice since it draws upon the inducible 
nature of K17 and provides a parallel analysis of the inducible nature of DDR markers as well, 
also providing a time sensitive, finely controlled approach to inducing DNA damage. Our 
findings indicate that treatment with the mutagen DMBA and the oxidative species H2O2 elicits 
an upregulation of K17 concurrent with a robust stimulation of the DNA damage response, as 
indicated by γH2AX staining, in skin keratinocytes isolated from mice tissue and seeded in 
primary culture.  
This piece of evidence was complemented by our ability to successfully visualize co-
localization of nuclear K17 and γH2AX, suggesting a potential physical association. However, 
the latter experiment was only carried out once (n=1 biological replicate) due to the fact that 
Hela cells are very sensitive towards LMB/TNF-α/TPA treatment and can result in cell death. 
Fortunately, recent mass-spectrometry data revealed a physical association between γH2AX 
and K17, further substantiating its possible interaction (unpublished observations, Justin Jacob, 
Coulombe laboratory). To validate this, co-immunoprecipitation could be carried out in the 
future to visualize molecular binding between the two proteins. Probing for other DDR markers 
is a plausible idea as well, and it would be interesting to see if K17 physically interacts with 
one or more effectors that play a role in sensing DNA damage, ahead of the repair response per 
se. ATM, for example, represents an interesting candidate, since this protein has been reported 
in literature to physically interact with γH2AX (Wang et al., 2016). Other upstream molecules 
in the DNA damage response are viable options as well; it would only substantiate our 
hypothesis if nuclear K17 is seen to physically associate with a plethora of DDR markers, 




In order to dissect the role that K17 plays in the DNA damage response, human tumor 
keratinocytes expressing K17 or lacking K17 were subjected to three types of insults: DMBA, 
H2O2, and IR. Analyses showed significant attenuation of the DDR in cells lacking K17, as 
indicated by lower γH2AX intensity. Extensive experimentation was carried out to assess the 
depth of K17’ impact on the DDR. Western blot analysis displayed a significant attenuation of 
DDR across a broad range of relevant markers when K17 is not present. Closer examination of 
the immunoblot data suggest that K17 is only impacting the damage proteins on a post-
translational level, since only the phospho-levels of markers being induced, not total protein 
levels, are typically affected. This result is concurrent with recent literature, where the DNA 
damage response is a transient event, where phosphorylating markers is a more effective means 
of signal transduction (Sulli, Di Micco & di Fagagna, 2012). Looking carefully, it is interesting 
to note that p-ATR is not dramatically different between the two genotypes, whereas p-ATM is. 
This suggests the possibility where nuclear K17 may not just play a sensing role following 
DNA damage, but a specific pathway in the DNA damage response. Thus, further experiments 
such as co-IP probing for ATM would be a worthy experiment. This differential impact of K17 
loff on ATM vs. ATR activation also raises the question of where and when is K17 performing 
its sensing abilities. Since the difference in the response to damage may be at the p-ATM/p-
ATR level, it suggests that K17 impacts the sensing at this level or higher upstream. To address 
this question, laser ablation experiments can be conducted to visualize the dynamics of DDR 
protein recruitment (Sun et al., 2016) to better understand if K17 is impacting a certain protein 
recruitment to sites of damage, or the activation of that protein, or both.  
To test if re-expressing Krt17 in human keratinocytes could rescue the DNA damage 
response, WT GFP-Krt17 was transiently transfected into A431 keratinocytes under the 
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treatment of either DMBA or H2O2. Detailed analysis with thorough quantification indicated a 
restoration of the DDR to a highly significant degree in Krt17 -/- keratinocytes transfected with 
WT GFP-Krt17, as indicated by a very high γH2AX intensity. Because the transfection 
protocol used is transient and is effective for a subset of cells in the dish, one could readily that 
cells displayed drastic differences in γH2AX intensity depending on whether they expressed 
WT GFP-Krt17 or not, providing a powerful internal reference. By contrast, transient 
transfection with related type I keratin, WT GFP-Krt14, or a K17 variant with compromised 
nuclear import, ΔNLS GFP-Krt17, resulted in no significant change in the rescue of the 
damage response.  
Consistent with the data already discussed above, K17 appears to impact most of the 
proteins involved in DNA damage by influencing the level of phosphorylation across different 
paradigms of DNA insults. However, it is worthwhile to note that the induction of p-ATR is not 
dependent on K17, hinting at the possibly that K17 may play a role in DDR through an ATM 
specific signaling event. Because the evidence showed K17 dependence in a plethora of 
proteins involved in DDR signaling, we hypothesized that K17 may be affecting the DDR at an 
even up-stream level of the damage response. This lead us to believe that K17 plays a sensing 
role in the damage response, consequently altering chromosome architecture, allowing DNA to 
be more susceptible towards external insults, resulting in enhanced DNA breakage. From this, 
we carried out a variety of experiments to determine this keratin’s ability to influence the level 
of DNA fragmentation. Tail-moments observed from comet assays were significantly longer in 
skin keratinocytes expressing Krt17 and were attenuated in the absence of K17. This piece of 
evidence solidified our confidence of this keratin’s ability to increase the levels of DNA 
breakage, leading us to conduct the MNase and DNA fragmentation assays for further 
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verification. Both of the assays conducted showed an increased level of DNA fragmentation 
when K17 was present.  
The findings reported in this thesis, when coupled with the body of work produced in 
the Coulombe laboratory and others, underscore the significance of K17 in a number of disease 
settings. In summary, we were able to arguably tether the realm of K17’s role in the DNA 
damage response to its ability to orchestrate chromatin architecture, ultimately determining the 
susceptibility of chromatin to fragmentation. These findings, taken together with previous 
experiments, suggests that K17 may play a role in sensing DNA damage, and therefore in the 
initiation the DNA damage response, by promoting the organization of nuclear DNA into a 
euchromatin state, thereby sensitizing it towards fragmentation. This, in turn, would result in an 
even higher activation of the DDR pathway. However, key questions remain: What is the 
purpose of K17 sensing or impact on the DDR as part of its inherent homeostatic functions in 
the human body? And how might this role be involved early on during tumorigenesis? 
Ultimately, cell fate experiments must be carried out in order to gain insight into these defining 
questions.  
To further expand on our knowledge of K17 involvement in DNA damage, future efforts could 
be directed as followed: i) ChIP-seq analyses may provide insight as to where K17 might be 
binding to the chromatin and what histone modifications, for instance, may be involved in its 
ability to alter chromosome architecture; ii) a more extensive investigation of K17 and its role 
in DNA repair by conducting in vitro non-homologous end joining (NHEJ) and homologous 
repair (HR) assays to elucidate if K17 is involved in a specific repair pathway; iii) perform 
additional assays that may further substantiate K17’s role in impacting chromatin organization 
in the nucleus, such a fluorescent in situ hybridization (FISH); iv) repeat the experiments 
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performed in this thesis project in murine models, given the new availability of the a K17 
ΔNLS knock-in mouse model to assess DNA damage; and iv) subject WT and Krt17 null mice 
to the two-step (DMBA/TPA) carcinogenesis protocol (need ref), with a particular focus on 
papilloma formation, to assess the role K17 has in the setting of tumor initiation in vivo. 
Completing those experiments would extend the findings of the current project, and validate (or 
not) the tentative conclusion that nuclear-localized K17 acts impact the extent of DNA damage 
as well as the response to it response primarily by altering chromatin structure and possibly by 
being part of the DNA damage sensing apparatus. The novel discovery of a role for K17 in 
DDR, coupled with its known role as a regulator of inflammation, suggests that this 
intermediate filament protein, when translocated into the nucleus, is able to promote these 














MATERIALS AND METHODS 
Cell lines 
Mouse epidermal keratinocytes were isolated for primary culture or immortalized as 
described previously. Parental A431 and HeLa cell lines (American Type Culture Collection) 
were confirmed to be mycoplasma free. The generation of A431 cells stably expressing shRNA 
targeting KRT17 was conducted by CRISPR-Cas9-mediated genome engineering. Specifically, 
a target sequence in the first exon of human KRT17 (5’-
GGCTCCTCCGGCCTGGGGGGCGG-3’(Pam motif underlined)) was chosen, and a 20 
nucleotide guide sequence (5’-GGCTCCTCCGGCCTGGGGGG-3’) was cloned into the BbsI 
site of pX458 (pSpCas9(BB)-2A-GFP, which is obtained from AddGene (plasmid 48138) 
according to the cloning protocol. For sequencing, the KRT17 regions targeted in the knockout 
cell line were PCR amplified and cloned into the pJET1.2/blunt cloning vector using the 
CloneJET PCR cloning kit (Life Technologies, K1231). Sequencing results showed a 
frameshift and premature stop codon formation for both alleles of KRT17.  
Mouse Models 
All experimental protocols involving mice were approved by the Johns Hopkins 
Institutional Animal Care and Use Committee. Genotyping for the Krt17+/+ and Krt17-/- alleles 
were conducted according to national protocols (National Cancer Institute Repository, strain 
01XT3; McGowan et al., 2002). FVB/N Krt17+/- and FVB/N Krt17-/- mice were utilized in this 
study.  
Tissue Collection  
36 
 
Ear tissues were harvested from five to six mice ( 2 month of age) for each genotype 
(Krt17+/- and Krt17-/- ) after a double topical DMBA (20 μg) or acetone treatment, 24 hours 
apart, then harvested one hour later after the second treatment. All tissue sections were quickly 
embedded in Tissue-Tec OCT compound (Sakura  Finetek, Torrance, CA, USA) and stored at -
20°C prior to sectioning. Tissue sections were cut at 8 μm in thickness and subsequently 
subjected to indirect immunofluorescent staining.  
Antibodies, reagents and plasmid constructs  
The primary antibodies used in these studies included rabbit polyclonal antibodies 
against Krt17 (McGowan, 1998), Sam 68 (Santa Cruz Biotechnology sc-333, Dallas, TX, 
USA); rabbit monoclonal antibodies against histone H3 (Cell Signaling #9715, Danvers, MA, 
USA), γH2AX (serine 139) (Cell Signaling #9718, Danvers, MA, USA), p53 (Cell Signaling 
#2527, Danvers, MA, USA), phospho-BRACA1 (Serine 1524) (Cell Signaling #9009, Danvers 
MA, USA), phospho-ATR (Serine 428) (Cell Signaling #2853, Danvers MA, USA), phosphor-
ATM (serine 1981) (Cell Signaling #5883, Danvers, MA, USA), PARP (Cell Signaling #9532, 
Danvers, MA, USA), phospho-Chk2 (threonine 68) (Cell Signaling #2197, Danvers, MA, 
USA), and phospho-Chk1 (serine 345) (Cell Signaling #2341, Danvers, MA, USA); mouse 
monoclonal antibody against phospho-p53 (serine 15) (Cell Signaling #9286, Danvers, MA, 
USA); normal rabbit IgG (Santa Cruz Biotechnology sc-2027, Dallas, TX, USA); mouse 
polyclonal antibodies against GAPDH (Santa Cruz Biotechnology sc-365062, Dallas, TX, 
USA). Secondary antibodies included ones conjugated to Alexa Flour 488 (Abcam, Cambridge, 
UK), Alexa Flour 647 (Abcam, Cambridge, UK) Alexa Flour 594 (Abcam, Cambridge, UK) 
for indirect immunofluorescence and horseradish peroxidase (HRP)-conjugated goat anti-
mouse and goat anti-rabbit antibodies (Sigma-Aldrich, St. Louis, MO, USA) for 
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chemiluminescence immunoblotting. 4’,6-Diamidine-2’-phenylindole   dihydrochloride (DAPI) 
(Roche 10236276001, Mannheim, Germany) was used as a marker for indirect 
immunofluorescence.  All antibodies were used according to the manufacture’s 
recommendation. TPA (Sigma, P1585) was dissolved in DMSO (for cell treatments) and used 
at 200 nM or 25 ng/ml working concentration, respectively. LMB (Sigma, L.2913) was 
dissolved in 70% methanol and used at a 40.7 nM working concentration. The Krt17 plasmid 
were transiently transfected into A431 cells using FuGENE HD (Promega, E2311) at a 1:3 
(DNA amount;FuGENE volume) ratio according to the manufacturer’s instructions. 
Micrococcal Nuclease 300 U/μL was obtained from Thermo Scientific #EN0181, Waltham, 
MA, USA.  
γ-Irradiation  
The γ-irradiation on A431 keratinocytes was performed using a 137Caesium source 
(dose rate 4 Gy/min).  
Western Blotting, Indirect Immunofluorescence and Microscopy 
Protein lysates for immunoblotting were prepared in urea sample buffer (8 M deionized 
urea, 0.5% SDS, 30 mM Tris, pH 6.8, 5% glycerol and 5% β-mercaptoethanol) after collecting 
whole cell lysates from cultured cells. All samples were sheared using progressively finger-
gauged needles (22 1/2, 25 1/2, and 26 ½) and subjected to a Bradford assay and processed. All 
samples were loaded at 10 μg of protein per lane for immunoblotting. Samples were separated 
using either 10% or 12.5% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
and transferred to 0.45µm nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) via a 
trans-blot turbo transfer system (Bio-Rad). Blots were blocked in 5% milk in TBST- T (w/v) 
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for >1hr at room temperature (21°C) and subsequently incubated overnight at 4°C in their 
appropriate antibodies. Secondary antibodies were applied for 1hr at room temperature (21°C). 
Blots were developed using either ECL Select developing solution (GE Healthcare, Pittsburgh, 
PA, USA) or SuperSignal West Pico chemiluminescent substrate (Thermo Scientific, Waltham, 
MA, USA) and imaged using a FluorChem Q system (ProteinSimple, San Jose, CA, USA). 
For indirect immunofluorescence analysis, frozen sections of the aforementioned tissues 
were blocked for 1hr at room temperature (21°C) in 5% normal goat serum and 1X PBS. 
Primary antibodies were applied overnight at 4°C. For cultured cells, they were needed on 
collagen coated glass cover slips (1:100 ratio of collagen and 0.2% acetic acid), then fixed and 
permeabilize with 4% paraformaldehyde and 0.2% TritonX, respectively. Primary antibodies 
were applied subsequently followed with secondary antibodies, with 30 minute incubations in 
between. Cover slips were mounted onto slides with FluoroSave TM reagent (345789-20ML, 
Calbiochem) and dried overnight. Both individual cells and tissue sections were imaged using a 
Zeiss fluorescence microscope with Apotome attachment (Zeiss, Oberkochem, German). 
Images for the same marker, across all samples and genotype were acquired at the same 
exposure, pixel range, gamma values and objective using Zen software. All images were 
consistently adjusted for brightness and contrast and appropriately cropped for presentation 
purposes using ImageJ software. 
Alkaline Comet Assays 
 Comet assays were conducted using the Comet Assay Kit (Trevigen) following the 
manufacturer’s instructions. A431 keratinocytes were mock treated or treated with DMBA, 
H2O2, or IR, with the indicated doses. Cells were collected and washed once with PBS, and 3 X 
105 cells were combined with 1% molten LMAgarose at 37 degrees Celsius at a ratio of 1:10 
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(v/v) and immediately pipetted onto slides. Slides were then immersed in pre-chilled lysis 
buffer to lyse cells, followed by alkaline unwinding of chromatin. Alkaline electrophoresis of 
gelled slides was conducted at 30V at 4 degrees Celsius for 30 minutes. The DNA was 
visualized by SYBR gold staining, and images were taken with a Zeiss fluorescence 
microscope with Apotome attachment, then analyzed by CometScore software (Tri-Tek, 
Sumerduck, Virginia).  
Micrococcal nucleus digestion assay  
 MNase digestion assay was carried out as previously described. Briefly, A431 
keratinocytes were washed with cold PBS and permeabilized with permeabilization solution 1 
(150 mM sucrose, 80 mM KCl, 35 mM HEPES, pH 7.4, 5 mM K2HPO4, 5 mM MgCl2, 0.5 
mM CaCl2) for 5 minutes. Solution was aspirated and treated with 0.05% lysolecithin for 1 
minute. The solution was then again aspirated and permeabilization solution 2 (150 mM 
sucrose, 50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 2 mM CaCl2) containing indicated 
concentrations of MNase were incubated at different time points. The reaction was stopped by 
adding stop solution buffer (20 mM Tris-HCl, pH 8.0, 20 mM NaCl, 20 mM EDTA, 1% SDS, 
0.6 mg/mL protinase K) and lysis dilution buffer (150 mM NaCl, 5 mM EDTA). Suspended 
homogenous solution was incubated overnight at 37 degrees Celsius with 4 uL of RNAase and 
TE buffer, pH 8.0. Phenol-chloroform extraction and ethanol precipitation was utilized to 
precipitate fragmented DNA, then subsequently separated by agarose gel electrophoresis, 





Image Quantification, Graphical Analysis and Description of Statistical Methods  
 Signal intensity quantification for indirect immunofluorescence images were performed 
using ImageJ software. The calculations were based on quantifying each individual cell within 
each field at 40X magnification, where the γH2AX signal intensity for each cell is measured 
(n=3 biological replicates). Background intensity was subtracted from each γH2AX signal 
intensity to be used as baselines. Graphs accompanying IF images represent the average overall 
arbitrary units of γH2AX levels in individual cell nuclei that were subjected to various DNA 
damaging agents. Error bars in quantification of immunofluorescence images represent 
technical error across multiple replicate images. All P-values were generated using a Student’s 
t-test with two-sided distribution and equal variance via Microsoft Excel. * denotes a P-value 
of <0.05; ** denotes a P-value of <0.02. Quantification for alkaline comet assays were 
performed using CometScore software. The calculations were based on measuring tail lengths 
for each individual cell within the field of microscopy, at 10X magnification. Graphs 
accompanying alkaline comet assays represent the average tail lengths between each treatment 
conditions and its respective genotype. Error bars in quantification of immunofluorescence 
images represent technical error across multiple replicate images. All P-values were generated 
using a Student’s t-test with two-sided distribution and equal variance via Microsoft Excel. * 
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EDUCATION 
 
        Johns Hopkins Bloomberg School of Public Health, Baltimore, MD                                   Expected May 2017  
        Master of Science, (Sc,M.)    
        Concentration: Biochemistry & Molecular Biology (Reproductive and Cancer Biology) 
        GPA: 3.9  
 
        Drew University, Madison, NJ                                                                                                                 May 2015 
        Bachelor of Arts, (B.A.)  
        Major: Biochemistry & Molecular Biology  
        Minor: Public Health 
        GPA: 3.5 
 
   RESEARCH EXPERIENCE 
 
 Graduate Researcher, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD  
    PI: Dr. Pierre Coulombe, Ph.D.                                                                                                  March 2016- 
Present 
• Original thesis research investigating the interplay between Keratin 17 and the DNA damage response to 
elucidate the keratin’s functional role in oncogenesis and chronic diseases. So far, not only does K17 play 
a role in DNA damage susceptibility, it also contains epigenetic qualities by shuttling into the nucleus 
and relaxing chromatin to express certain genes.  
• K17 dependence on DNA damage was evaluated with western blots derived from CRISPR-Cas generated 
KO cell lines and mice colonies. Additional techniques such as comet assays, immunofluorescent 
staining was utilized to compliment the data. MNase hypersensitivity assays and CHIP sequencing were 
utilized to elucidate the role of keratin 17 on chromatin organization.  
  
Graduate Research Assistant, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD  
    PI: Dr. Phillip Jordan, Ph.D.                                                                                                             Sep 2015-Feb 
2016 
• Assisted in the investigation of Aurora kinases/SMC proteins and their role in carcinogenesis and 
infertility by performing westerns and chromosome spreads needed for fluorescence microscopy.  
• Performed seminiferous tubule squashes for the analysis of male chromosome dysregulation 
• Histological analysis of seminiferous tubules and preantral follicles. 
Undergraduate Research Assistant, Drew University RISE, Madison, NJ   Oct 
2012-June 2015 
    Advisor: Dr. Ronald J. Doll, Ph.D. 
• Drug discovery project: Synthesized and purified novel benzimidazole and quinoline class compounds via 
standard organic chemistry techniques. Compounds were characterized by LC/MS, GC/MS, and NMR. 
They were then tested for reactivation of mutant p53 in human tumor cells lines via westerns and cell 
viability assays. 
• Established Drug Metabolism and Pharmacokinetics (DMPK) of synthesized compounds to determine 
drug absorption, metabolism, permeability and toxicity.  
• Successfully synthesized analogs of Kevetrin™, an anti-cancer agent in phase 1 clinical trials. 
  
Clinical Research Assistant, Weill Cornell Medical Center, New York, NY                     
June-Aug 2014                                                      
54 
 
 Advisors: Dr. Fun-Sun Frank Yao, M.D. and Michele L. Steinkamp, RNS 
• Analyzed coagulation efficiency of patients with various illnesses utilizing a ROTEM, and calculation and 
analysis were performed in excel.  
• Obtained patient consent for clinical trial enrollment.  
• Obtained and analyzed clinical research data and organized and maintained patient medical history. 
• Investigated the effects of dexamethasone administered pre-operatively to patients undergoing Caesarian-
sections by obtaining follow up PONV (Post-operative nausea vomiting) analysis  
Anesthesiology Department Intern, Weill Cornell Medical Center, New York, NY                     
June-Aug 2014                                                      
 Advisors: Dr. Fun-Sun Frank Yao, M.D. and Michele L. Steinkamp, RNS 
• Learned the basics of anesthesia, such as the function of anesthesia machine and its ability to measure 
electrocardiogram (EKG), Heart rate, blood pressure and sustain proper oxygen saturation to utilize 
Desflurane to control the levels of propofol. Learned about many anesthetics and their functions, such as 
propofol, Succinylcholine, Fentanyl, Phenylephrine, etc.  
• Understood anesthesiology pre-operative evaluations, such as obtaining patient medical history to 
determine if factors like sleep apnea, acid reflux, and past surgical history would impede tracheal 
intubation. 
• Witnessed numerous specialized and complex procedures such as general surgery, interventional 
radiology, endoscopy, colonoscopy, acute pain management, obstetric anesthesia, kidney stone removal, 
cardiac surgery, caesarean section, and electroconvulsive therapy (ECT). 
 
SELECTED PRESENTATIONS  
 
• Joshua Hsu. Drug Discovery: Investigation of Drug Metabolism of compounds that target mutant p53. 
Presented at the North Jersey American Chemistry Society Section’s 67th Annual Undergraduate Research 
Conference, Teaneck, NJ, 2015.  
• Joshua Hsu. 8-Quinolyl-N-arylcarbamates as re-activators of mutant p53 and potential anti-tumor agents, 
MEDI 287, Am Chem Soc. Presented at the American Chemistry Society National Meeting, Philadelphia, 
PA, 2012. 
• Joshua Hsu. Nuclear Keratin 17 and its role in the DNA Damage Response. Presented at the Johns 
Hopkins Bloomberg School of Public Health Department of Biochemistry & Molecular Biology Research 








• Master of Health Science (M.H.S.) Thesis: Self-Assembled Aptamer Complexes as a Novel Therapeutic 
for targeted Alisertib delivery against Aurora A in Breast Cancer. 




• 8-Quinolyl-N-arylcarbamates as re-activators of mutant p53 and potential anti-tumor agents, MEDI 287, 
Am Chem Soc. National Meeting, Philadelphia, PA, 2012. 
• Ryan P. Hobbs, Joshua Hsu, Justin T. Jacob, Pierre A. Coulombe. “A role for nuclear-localized keratin 
17 in the response of skin tumor keratinocytes to DNA damaging agents.” Society for Investigative 
Dermatology. Portland, OR, 2017.                 
• Joshua Hsu, Ryan P. Hobbs, Pierre A. Coulombe. “Nuclear Keratin 17 and its role in the DNA Damage 




WORK EXPERIENCE  
 
Assistant, Residential School on Medicinal Chemistry and Biology, Madison, NJ                        June 2015-July 
2015 
• Assisted fellow residents throughout the residential school by organizing various events for smooth 
lectures.  
• Attended several lectures on medicinal chemistry, subjected included: fragment-based drug design, 
clinical development, pharmacokinetics, enzymology, G-coupled protein receptors, Chemoinformatics, 
and case histories on drug development for many marketed drugs, such as eltrombopag and adcetris. 
 
Subject Tutor, Drew University Center of Academic Excellence, Madison, NJ                              Oct 
2013-Mar 2014  
  Cardinal Scholars, Madison, NJ     Feb 
2014-Apr 2014 
• Tutored students in organic chemistry, biochemistry and molecular biology 
Teaching Assistant, Drew University Chemistry Department, Madison, NJ   Sep 
2013-Dec 2013 




              
 
ALTRUISTIC EXPERIENCE  
 
 
Case Manager, Charm City Clinic, Baltimore, MD      Feb 
2016-Present 
• Provide guidance and assistance to patients in dire need of health insurance and a primary  
care physician. 
• As a member of the health resource center (HRC), I also provide assistance to patients in need of various 
programs that aid with their alcoholism and drug abuses.  
  
Administrative Volunteer, Shepard’s Clinic, Baltimore, MD      Nov 
2016-Present 
• Responsible for contacting patients for appointments and organizing patient data files.  
• Assist in cleaning the clinic whenever possible, and encourage patients to sign up for various fun 
activities that the Joy and Wellness Center provides. 
 
Head of Family Mentor, Thread, Baltimore, MD                                                                                Sep 2016-
Present 
• Provide guidance to an assigned troubled student attending school in Baltimore city by directing reaching 
out to the students and their families, working with other Thread members on a plan to help students 
graduate high school and attend a four-year undergraduate institution.  
 
Volunteer, Baltimore Rescue Mission Medical Clinic, Baltimore, MD     Sep 
2015-Dec 2015  
• Assisted patients and local medical residents in diagnosing and treating homeless population in the 
Baltimore city area.  
• Obtained past patient medical history for proper diagnosis.  
• Utilized blood lancets to measure blood glucose levels.  




Volunteer, Uni-med Family Health Care, Brooklyn, NY   June 
2015-Aug 2015  
• Assisted patients in an underserved area by collecting blood work, utilizing phlebotomy and other 
venipuncture techniques. 
• Obtained and analyzed cardiac electrical activity of patients using electrocardiogram (EKG). 
• Assisted with patient physical check up by measuring blood pressure and auscultation. 
• Analyzed CT scans to assist with patient cancer diagnosis. 
• Performed vaccinations and vitamin B12 shots.  
 
Volunteer, Drew University Civics Scholars Humanitarian Relief, Staten Island, NY     Oct 
2012-Nov 2012  
• Assisted local residents affected by Hurricane Irene by organizing supplies for the homeless.  
• Tore down and rebuilt damaged houses to recover personal property and ensure a safer environment. 
• Delivered food and water.  
Missionary Personnel, The Presbyterian Church in Taiwan, Taipei    June 
2011-Jul 2011 
• Organized and reestablished church and tribal events for the local aboriginals of Hong-Ye. 
• Cleaned elderly shelters and taught English to a class of children.  
 
AWARDS AND HONORS  
 
• Dean’s Honor List 2012, 2013, 2014, 2015  
• Drew University Dean's Award Scholarship 
• Tri-Beta Honor Society (Upsilon Delta Chapter)  






Biology Laboratory Techniques: 
• Western blotting, PCR, qRT-PCR, qPCR, Nested PCR, SDS-PAGE, DNA/RNA isolation and 
purification, genome cloning, sequence analysis, chromosome spreads, and gel electrophoresis. 
Culture and aseptic techniques, gram staining, plasmid midiprep, serial dilution, LB agar medium 
preparation, bacterial transformation, bacterium inoculation, human microsome metabolism assay, in 
vivo tissue isolation, intraperitoneal (IP) injections, cryosectioning, hematopoietic stem cell isolation, 
splenocyte isolation, chemical inhibition assay, chemotaxis assay, MTT assay, stem cell culturing, 
tissue culture, migration assay, luciferase reporter assay, ELISA assay, histology analysis, tubule 
squashes, immunoprecipitation, immunofluorescence staining, lipophilic & optical transfection, comet 
assays, Mnase assay, chromosome spreads.  
 
    Chemistry Laboratory Techniques: 
• Extraction, reflux, titration, filtration, vacuum filtration, distillation, TLC, flash column 
chromatography, affinity chromatography and recrystallization 
 
Equipment Skills:  
• Utilized various amount of research equipment such as a Rotary evaporator, fluorescence microscopy, 
UV-Vis spectrophotometer, spectrophotometer, LC/MS, GC/MS, NMR, IR, Chiral column 
Chromatography, affinity chromatography, streptavidin pulldown, flow cytometer, NanoDrop 
spectrophotometer and 2D-NMR (COSY), Confocal Microscope 
 
Computer Programs Skills: 
• ChemDraw, Java, Microsoft programs (World, PowerPoint, Excel, Excess), Adobe programs 








Drew University:                                                                      Johns Hopkins Bloomberg School of Public 
Health: 
 
Principles of Chemistry I                                               
Principles of Chemistry II                                              
Introduction to Psychology  
Molecular and Cellular Biology  
Organic Chemistry I  
Organic Chemistry II  
Microbiology  
Calculus and Analytical Geometry I  
Calculus and Analytical Geometry II  
Introductory Statistics  
Biochemistry I  
Vertebrate Anatomy and Physiology I  
Vertebrate Anatomy and Physiology II  
Molecular Genetics  
Chemical Biology  
Biological Psychology  
Bio-Medical Ethics  
Virology  
Molecular Biology of Cancer  
Research in Biochemistry  
Research in Chemistry  
Immunology  





Fundamentals of Reproductive Biology   
Introduction to Molecular Biology  
Molecular Toxicology  
Evolution of Infectious Diseases  
Fundamentals of Human Physiology 
Principles of Cell Biology  
Clinical Oncology  
Immunology, Infection, and Disease  
Molecular Biology of Pandemic Influenza  
Pathogenesis of Bacterial Infections  
Autoimmune diseases of the endocrine 
glands 
Neurotoxicology  
Mechanisms of Cardiopulmonary Control  
Genetics and Gene Therapy  
Nucleic Acid Chemistry  
Molecular and Cellular Mechanisms of 
Reproduction  
Genome Integrity and Cancer  
Practical Epidemiology for Basic Scientists  
Clinical Immunology 
Principles of Neuroimmunology  
MHS Thesis in Reproductive and Cancer 
Biology  
ScM Thesis: K17’s Role in DNA damage 
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